Menu
An expanding Nordic platform advancing Multiple Myeloma studies and treatment
There is growing optimism that multiple myeloma is on its way to become a chronic disease. The improving survival rate is partly attributed to the efforts of physicians like Dr. Fredrik Schjesvold from the Oslo Myeloma Center at Oslo University Hospital. Listen to our podcast as Dr. Schjesvold describes his efforts to build an infrastructure that will make Norway an attractive partner for early phase studies, and the progress that is being made to predict how well patients respond to treatment and the ability to identify the best, least toxic treatment option.
CP-128567 updated on 28-11-2019
CP-128567 updated on 28-11-2019
